Browsing by Author "Trivedi, H H"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
Item Captopril in congestive cardiac failure.(1986-11-01) Misra, N P; Manoria, P C; Trivedi, H H; Mehrotra, Y; Pandey, PItem Clinical profile of gas leak victims in acute phase after Bhopal episode.(1987-01-01) Misra, N P; Pathak, R; Gaur, K J; Jain, S C; Yesikar, S S; Manoria, P C; Sharma, K N; Tripathi, B M; Asthana, B S; Trivedi, H HItem Electrocardiographic changes in the first month of life.(1981-01-01) Misra, N P; Manoria, P C; Bhargava, R K; Trivedi, H H; Gulati, B; Kanojiya, R SItem Evaluation of trimipramine in the management of peptic ulcer.(1985-02-01) Tripathi, B M; Misra, N P; Rao, S; Saifi, A Q; Trivedi, H H; Singh, R; Nigam, TItem Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.(1978-09-01) Jhawar, B K; Trivedi, H H; Bhargava, R K; Misra, N PItem Value of DOPEG estimation in CSF in depression.(1990-12-01) Johri, M S; Misra, N P; Gaur, K J; Trivedi, H H3,4-Dihydroxyphenyl ethylene glycol (DOPEG), a metabolite of noradrenaline (NA), was estimated in CSF of 30 patients of depression diagnosed by the criteria of American Psychiatric Association in DSM-III; and compared with levels in 10 non-depressed individuals who served as controls. Mean DOPEG levels in CSF in the patient group (801.37 +/- 28.09 micrograms/l) were significantly higher (P less than 0.01) than those in the control group (724.3 +/- 34.62 micrograms/l). Formation of excessive amount of this particular metabolite suggests an excessive intraneuronal deamination of NA, partially accounting for the overall decline in the availability of NA in the noradrenergic neurons in patients of depression.